Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Breast 7Gastrointestinal 4Genitourinary 3Thoracic 2Gynecologic 2Tumor-Agnostic 1Sarcoma 1Other solid neoplasm 1Other 1Lymphoid 1Endocrine 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Biomarkers × Gastrointestinal × Clear all
NCT02893085 2016-12-28

ONCOBIL

CHU de Reims

Completed
100 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT00834236 2015-12-07

Proteiomic Fingerprints of Gastric Juice

Kaohsiung Veterans General Hospital.

Phase NA Completed
76 enrolled 6 charts
Gastrointestinal

Stomach Neoplasms

NCT02280070 2014-10-31

RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).

Clinical Research Support Center Kyush

Phase 2 Unknown
110 enrolled
Gastrointestinal

Rectal Neoplasms

NCT00855348 2014-08-04

PRESEPT

Epigenomics, Inc

Completed
7,929 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡